The Sackler Case Comes to a Close; Final Analysis and the Importance of Holding Pharma Companies Accountable
Consider this: Purdue Pharmaceuticals/the Sacklers versus thousands of plaintiffs nationwide. It was one of the most closely watched pharmaceutical litigations of our time, and it just came to a close. While there were some small victories in the case, many see its outcome as a loss for those who suffered at the hands of Purdue’s addictive opioid painkiller, OxyContin.
Forty-seven U.S. States have filed lawsuits against Purdue Pharma, requesting a total of $2.2 trillion dollars as compensation for Purdue’s contributions to the opioid epidemic. Is this a fair number?
Everyone loves a good conspiracy. Or, we like to think that we do, but we all know that life would be a whole lot better if the conspiracies never happened in the first place. The drama and the subterfuge might be interesting at first, but it always comes at a cost.
Just when we thought we had heard it all when it comes to drug and alcohol addiction in the 21st century, the newest information to hit the airwaves is that opioid addicts are now experimenting with anti-diarrhetic drug . No, you did not misread that.